Carbetocin Acetate
Reproductive & endocrine
Research mainly concerns prevention of postpartum haemorrhage.
An authorisation applies to at least one defined finished product in a stated jurisdiction; it does not apply automatically to this catalogue material.
What is Carbetocin Acetate?
Carbetocin acetate is a synthetic oxytocin analogue peptide used in reproductive pharmacology research; the catalogue item denotes the acetate salt research material supplied for laboratory study.
Which research context has Carbetocin Acetate been associated with?
Carbetocin Acetate is associated with reproductive endocrine research focusing on uterotonic pharmacology and prophylaxis of postpartum haemorrhage in peripartum study contexts, including formulation and stability work.
What documentation is available for Carbetocin Acetate?
Carbetocin Acetate: Batch documents are not yet linked on this site. For this synthetic oxytocin analogue peptide required evidence comprises batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity criteria; peptide content, counterion and residual solvent/water declaration; and assay/potency method supporting release. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Carbetocin Acetate?
Carbetocin Acetate: Storage depends on the documented supplied presentation; for this synthetic oxytocin analogue peptide confirm dry/lyophilised versus solution supply, counterion and concentration, solvent or buffer choice, pH sensitivity, container closure compatibility and whether conformational or disulfide integrity is relevant to stability. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.